ABP 959 for treating paroxysmal nocturnal
haemoglobinuria


featured image

ABP 959 is in development for the treatment of paroxysmal nocturnal haemoglobinuria (PNH). PNH is a rare condition, which occurs due to a genetic mutation within stem cells in the bone marrow.

Interventions: ABP 959
Therapeutic Areas: Haematology
Year: 2022

ABP 959 is in development for the treatment of paroxysmal nocturnal haemoglobinuria (PNH).
PNH is a rare condition, which occurs due to a genetic mutation within stem cells in the bone
marrow. In PNH, red blood cells lack specific proteins on their surface which normally protect
them from being destroyed (a process called haemolysis) by the body's normal defence system.
PNH is characterised by the presence of brownish urine.